{"url":"https://lda.senate.gov/api/v1/filings/aef03896-bb60-485b-b1ad-31b67e74737f/","filing_uuid":"aef03896-bb60-485b-b1ad-31b67e74737f","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2021,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/aef03896-bb60-485b-b1ad-31b67e74737f/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Adam J. Biegel","dt_posted":"2021-04-21T00:01:17.703000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"THE ATLANTIC BUILDING","registrant_address_2":"950 F STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":1182,"url":"https://lda.senate.gov/api/v1/registrants/1182/","house_registrant_id":31748,"name":"ALSTON & BIRD LLP","description":"Law Firm","address_1":"THE ATLANTIC BUILDING","address_2":"950 F STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ADAM J. BIEGEL","contact_telephone":"+1 202-239-3692","dt_updated":"2026-02-26T13:05:14.829555-05:00"},"client":{"id":102518,"url":"https://lda.senate.gov/api/v1/clients/102518/","client_id":1006637,"name":"TRAVERE THERAPEUTICS","general_description":"Prescription pharmaceutical manufacturer of medications.","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-11-11"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Legislation regarding diagnosis and treatment of rare kidney diseases.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10566,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"RAYDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54867,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"SIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":21262,"prefix":"ms","prefix_display":"MS.","first_name":"MARILYN","nickname":null,"middle_name":"K","last_name":"YAGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":38828,"prefix":null,"prefix_display":null,"first_name":"ELINOR","nickname":null,"middle_name":null,"last_name":"HILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71092,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"A","last_name":"SHAW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Newborn Screening Saves Lives Act Reauthorization, H.R. 482, S. 350. FY 2022 CDC Appropriations for newborn screening technical assistance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10566,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"RAYDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54867,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"SIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":21262,"prefix":"ms","prefix_display":"MS.","first_name":"MARILYN","nickname":null,"middle_name":"K","last_name":"YAGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71092,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"A","last_name":"SHAW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":38828,"prefix":null,"prefix_display":null,"first_name":"ELINOR","nickname":null,"middle_name":null,"last_name":"HILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 366, Protecting Access to Post-COVID-19 Telehealth Act and related legislation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10566,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"RAYDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54867,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"SIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":21262,"prefix":"ms","prefix_display":"MS.","first_name":"MARILYN","nickname":null,"middle_name":"K","last_name":"YAGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":38828,"prefix":null,"prefix_display":null,"first_name":"ELINOR","nickname":null,"middle_name":null,"last_name":"HILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71092,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"A","last_name":"SHAW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Legislative proposals regarding drug pricing and reimbursement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10566,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"RAYDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":38828,"prefix":null,"prefix_display":null,"first_name":"ELINOR","nickname":null,"middle_name":null,"last_name":"HILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71092,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"A","last_name":"SHAW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}